Invention Grant
- Patent Title: Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
-
Application No.: US14809314Application Date: 2015-07-27
-
Publication No.: US09458113B2Publication Date: 2016-10-04
- Inventor: Stefan Peters , Ralf Anderskewitz , Christian Gnamm , Holger Hoesch , Gerd Morschhaeuser , Thorsten Oost , Uwe Joerg Ries
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP14179259 20140731
- Main IPC: C07D239/70
- IPC: C07D239/70 ; C07D401/10 ; C07D403/10 ; C07D405/12 ; C07D413/10 ; C07D417/10 ; A61K31/517 ; A61K31/5355
Abstract:
Substituted dihydropyrimidinones of formula 1 which are neutrophil elastase inhibitors and useful as medicaments for the treatment of, inter alia, COPD. Exemplary is
Public/Granted literature
- US20160031830A1 SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY Public/Granted day:2016-02-04
Information query
